Historical “amyloid disease” denotes the waxy or lardaceous visceral change, especially in the spleen, liver and kidneys; modern amyloidosis denotes deposition of misfolded protein fibrils. The old descriptive appearance and the modern chemical explanation must be kept distinct.
In nineteenth-century usage the affected organs could be enlarged, firm and unusually translucent or wax-like on section. The name amyloid means starch-like. The historical chemical argument relied on colour reactions with iodine and sulfuric acid, suggesting affinity with starch or cellulose. Such a reaction was a clue to recognition, not a modern identification of the deposited substance. Rudolf Virchow's 1856 account explicitly discusses the waxy change of the spleen, liver and kidneys, and its occurrence with longstanding destructive disease.[ref]
On the Course of the Amyloid Degeneration by Rudolf Virchow. 1856 English abstract, pp. 380–383, opening account of visceral sites and chronic disease
The three principal visceral examples can be described more precisely:
- In the spleen, deposits in the splenic white pulp may produce translucent granules, the so-called sago spleen. More diffuse involvement gives a widespread lardaceous appearance.
- In the liver, deposits along the hepatic sinusoids can compress adjacent hepatocytes; extensive deposition may produce a large firm liver.[ref]Hepatic amyloidosis: morphologic differences between systemic AL and AA types. Abstract, autopsy examination of 286 livers; sinusoidal and portal patterns
- In the kidney, deposits in glomeruli, blood vessels and sometimes the interstitium interfere with function. Involvement of the glomeruli explains the albuminuria of Question 1; it may progress to nephrotic syndrome and kidney failure.
The distribution is not confined to those three organs. Amyloidosis can also affect the gastrointestinal tract, heart, blood vessels and other sites; the pattern depends on the precursor protein. Modern examples include AA amyloidosis associated with sustained inflammation, AL amyloidosis involving immunoglobulin light chains, and transthyretin amyloidosis. This classification is a present-day explanation, not a list of molecular diagnoses asserted for unnamed 1867 patients.[ref]
Amyloidosis by Merck Manual Professional Edition. Introduction; Etiology, systemic types and common sites of deposition
Modern confirmation uses histology with Congo red and examination with a polarizing microscope, followed by identification of the deposited protein, for example with mass spectrometry. The characteristic birefringence supports identification of amyloid; typing distinguishes biologically different diseases. These are later laboratory methods, not apparatus available to the candidate in 1867.[ref]
Sago spleen 2026-10-31
A gross pattern of amyloidosis of the spleen in which translucent deposits in the splenic white pulp resemble sago grains. The pattern can accompany different forms of amyloidosis.[ref]
Hepatic amyloidosis: morphologic differences between systemic AL and AA types. Abstract, sago pattern and limits of anatomical typing